-
Posted: December 6th, 2019, 3:00pm GMT
Condition: Post-thoracotomy Pain Syndrome
Intervention: Procedure: Thoracic epidural analgesia , superficial serratus plane block and deep serratus plane block
Sponsor: National Cancer Institute, Egypt
Recruiting
-
Posted: December 5th, 2019, 3:00pm GMT
Conditions: Adrenocortical Carcinoma; Pheochromocytoma; Paraganglioma
Intervention: Biological: EO2401
Sponsor: Enterome
Not yet recruiting
-
Posted: October 28th, 2019, 2:00pm GMT
Conditions: Pain; Supratentorial Brain Tumor
Interventions: Drug: Ketorolac; Drug: Ropivacaine; Drug: Epinephrine
Sponsor: Beijing Tiantan Hospital
Not yet recruiting
-
Posted: October 15th, 2019, 2:00pm GMT
Conditions: Adrenal Incidentaloma; Hypercortisolism; Adrenal Tumor
Intervention: Procedure: Adrenalectomy
Sponsor: University of Roma La Sapienza
Recruiting
-
Posted: September 27th, 2019, 2:00pm GMT
Conditions: Locally Advanced Adrenal Gland Pheochromocytoma; Locally Advanced Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Paraganglioma; Metastatic Parathyroid Gland Carcinoma; Pituitary Gland Carcinoma; Somatostatin Receptor Positive; Stage III Thyroid Gland Medullary Carcinoma AJCC v8; Stage IV Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVA Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVB Thyroid Gland Medullary Carcinoma AJCC v8; Stage IVC Thyroid Gland Medullary Carcinoma AJCC v8; Unresectable Adrenal Gland Pheochromocytoma; Unresectable Paraganglioma
Intervention: Drug: Lutetium Lu 177 Dotatate
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: September 19th, 2019, 2:00pm GMT
Condition: Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
Intervention: Drug: ASP1948
Sponsor: Astellas Pharma Inc
Recruiting
-
Posted: September 11th, 2019, 2:00pm GMT
Conditions: Thyroid; Parathyroid Adenoma
Interventions: Drug: Lidocaine Epinephrine; Drug: Bupivacaine Hydrochloride-EPINEPHrine; Drug: Lidocaine Epinephrine, Bupivacaine Hydrochloride-EPINEPHrine
Sponsor: University of Missouri-Columbia
Not yet recruiting
-
Posted: September 11th, 2019, 2:00pm GMT
Conditions: Nephrectomy, Anesthesia, Regional, Patient-controlled, Analgesia; Kidney Diseases
Interventions: Drug: Ropivacaine injection; Other: Sham
Sponsors: McMaster University; St. Joseph's Healthcare Hamilton
Not yet recruiting
-
Posted: September 4th, 2019, 2:00pm GMT
Condition: Acute Inflammatory Response to Psychological Stress
Interventions: Behavioral: Socio-evaluative speech task, then Control; Behavioral: Control, then Socio-evaluative speech task
Sponsors: University of Pittsburgh; National Institute of Mental Health (NIMH)
Not yet recruiting
-
Posted: August 19th, 2019, 2:00pm GMT
Condition: Metastatic Castration-resistant Prostate Cancer
Intervention: Drug: Phase I and Phase II: LAE001/prednisone + afuresertib
Sponsor: Laekna Limited
Recruiting
-
Posted: August 15th, 2019, 2:00pm GMT
Conditions: Colon Adenocarcinoma; Colon Cancer
Intervention: Other: Exercise assessment
Sponsors: Northumbria University; York St John University; Newcastle University
Recruiting
-
Posted: August 14th, 2019, 2:00pm GMT
Conditions: Breast Cancer Female; Pain, Postoperative
Interventions: Procedure: Thoracic paravertebral block under ultrasound guidance; Procedure: Intraoperative modified PEC block; Procedure: GA with ETT
Sponsor: Mahidol University
Recruiting
-
Posted: July 25th, 2019, 2:00pm GMT
Conditions: Gastric Neoplasm; Early Gastric Cancer
Interventions: Procedure: Endoscopic submucosal dissection; Drug: Epinephrine
Sponsors: Chinese University of Hong Kong; Osaka International Cancer Institute; Shizuoka Cancer Center; Fukuoka University; Changi General Hospital; Kyoto 2nd Red Cross Hospital; Ishikawa Prefectural Central Hospital; Kosin University Gospel Hospital
Recruiting
-
Posted: July 22nd, 2019, 2:00pm GMT
Conditions: Adenocarcinoma; Adenocystic Carcinoma; Anal Cancer; Appendix Cancer; Brain Tumor; Glioblastoma; Astrocytoma; Bile Duct Cancer; Cholangiocarcinoma; Bladder Cancer; Bone Cancer; Synovial Sarcoma; Chondrosarcoma; Liposarcoma; Sarcoma, Kaposi; Sarcoma,Soft Tissue; Sarcoma; Osteosarcoma; CNS Cancer; Brain Stem Neoplasms; Breast Cancer; Cervical Cancer; Colorectal Cancer; Rectal Cancer; Colon Cancer; Esophageal Cancer; Esophagus Cancer; Cancer of Colon; Pancreatic Cancer; Cancer of Pancreas; Testis Cancer; Testicular Cancer; Ureter Cancer; Renal Cell Carcinoma; Kidney Cancer; Gestational Trophoblastic Tumor; Head and Neck Neoplasms; Parotid Tumor; Larynx Cancer; Tongue Cancer; Pharynx Cancer; Salivary Gland Cancer; Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia; Multiple Myeloma; Non Hodgkin Lymphoma; Carcinoid Tumor; Lung Cancer; Neuroendocrine Tumors; Mesothelioma; Thyroid Cancer; Parathyroid Neoplasms; Adrenal Cancer; Small Bowel Cancer; Stomach Cancer; Liver Cancer; Hepatic Cancer; Melanoma; Skin Cancer; Unknown Primary Tumors; Uterine Cancer; Fallopian Tube Cancer; Ovarian Cancer; Prostate Cancer; Vaginal Cancer; Penile Cancer; Vulvar Cancer; Waldenstrom Macroglobulinemia; Cancer, Advanced; Thymus Cancer; Nasopharyngeal Carcinoma; Multiple Endocrine Neoplasia; Pheochromocytoma; Small Cell Carcinoma; Pulmonary Carcinoma
Interventions: Diagnostic Test: Testing: Genome; Diagnostic Test: Testing: Transcriptome; Diagnostic Test: Testing: Proteome; Drug: Treatment: CAR-T
Sponsor: Taproot Health
Not yet recruiting
-
Posted: July 19th, 2019, 2:00pm GMT
Conditions: Lung Cancer; Postoperative Pain
Interventions: Drug: Thoracic epidural; Drug: Paravertebral block
Sponsor: St. Olavs Hospital
Recruiting
-
Posted: July 15th, 2019, 2:00pm GMT
Conditions: Breast Cancer; Mastectomy; Anesthesia, Local; Narcotic Use
Interventions: Drug: PECs block with local anesthesia of bupivacaine with steroid; Other: Placebo PECs block with normal saline
Sponsor: University of Alabama at Birmingham
Not yet recruiting
-
Posted: June 19th, 2019, 2:00pm GMT
Conditions: Primary Aldosteronism; Primary Aldosteronism Due to Aldosterone Producing Adenoma
Intervention: Combination Product: 11C-Metomidate PET/CT Scan
Sponsors: Changi General Hospital; National University Health System, Singapore; Clinical Imaging Research Centre; Singapore General Hospital; Tan Tock Seng Hospital; Khoo Teck Puat Hospital; Ng Teng Fong General Hospital
Recruiting
-
Posted: June 14th, 2019, 2:00pm GMT
Conditions: Neoplasm Metastasis; Thyroid Neoplasm; Pheochromocytoma; Adrenal Neoplasm; Neuroendocrine Tumors; Bone Metastases
Intervention: Device: cryoablation
Sponsors: Instituto do Cancer do Estado de São Paulo; University of Sao Paulo General Hospital
Recruiting
-
Posted: May 22nd, 2019, 2:00pm GMT
Condition: Breast Cancer
Interventions: Drug: Ipatasertib; Drug: Fulvestrant; Drug: Aromatase Inhibitor; Drug: Palbociclib
Sponsors: Massachusetts General Hospital; Genentech, Inc.
Recruiting
-
Posted: April 18th, 2019, 2:00pm GMT
Condition: Colorectal Neoplasms
Interventions: Drug: Propranolol and etodolac; Other: Placebo
Sponsors: Assaf-Harofeh Medical Center; Sheba Medical Center; Rabin Medical Center; Tel-Aviv Sourasky Medical Center; Rambam Health Care Campus; HaEmek Medical Center, Israel
Recruiting
-
Posted: April 4th, 2019, 2:00pm GMT
Conditions: Lung Cancer; Lung Diseases
Interventions: Procedure: ESP block; Procedure: Intercostal block; Procedure: Sham ESP block; Procedure: Sham Intercostal block; Drug: Bupivacaine-epinephrine; Drug: Dexamethasone injection; Drug: Normal saline
Sponsor: McGill University Health Center
Recruiting
-
Posted: April 1st, 2019, 2:00pm GMT
Conditions: Cancer, All Types; Cancer of Liver; Cancer of Stomach; Cancer of Head and Neck; Cancer of Rectum; Cancer of Kidney; Cancer of Esophagus; Cancer of Colon; Cancer Skin; Cancer of Cervix; Cancer, Metastatic; Cancer of Larynx; Cancer of Neck; Cancer of Lung; Cancer of Brain and Nervous System; Cancer of Vulva, Disseminated; Cancer of Pancreas; Sarcoma; GIST; Small-cell Lung Cancer; Adenocarcinoma Lung; Cancer of Prostate; Cancer, Advanced; Adrenal Cancer; Testicular Cancer; Uterine Cancer; Bronchoalveolar Cell Lung Cancer; Cancer Unknown Primary; Glioblastoma Multiforme; Oligodendroglioma; Breast Cancer; Renal Cell Carcinoma; Hepatocellular Carcinoma; Cholangiocarcinoma; Squamous Cell Carcinoma; Transitional Cell Carcinoma; Cancer, Other; Cancer, Anal; Melanoma; Cancer, Bile Duct; Cancer, Bladder; Cancer Cords Vocal; Cancers Cell Neuroendocrine; Cancer Differentiated Poorly; Cancer, Anaplastic Thyroid
Intervention:
Sponsors: SpeciCare; Dana-Farber Cancer Institute; Kalispell Regional Medical Center; Georgia Institute of Technology; Ontario Institute for Cancer Research; SEngine Precision Medicine; Helomics
Recruiting
-
Posted: March 12th, 2019, 2:00pm GMT
Conditions: Lidocaine; Bupivacaine; Mohs Surgery; Anesthetic
Interventions: Drug: Lidocaine; Drug: Bupivacaine; Drug: Lidocaine and Bupivacaine
Sponsors: Ottawa Hospital Research Institute; Richard J. MacKay Endowment Fund; Benefactor Life Members’ Research Grant; The Ottawa Hospital Division of Dermatology
Not yet recruiting
-
Posted: March 5th, 2019, 3:00pm GMT
Condition: Metastatic Tumors
Interventions: Radiation: palliative radiotherapy; Radiation: Stereotactic ablative radiotherapy
Sponsors: British Columbia Cancer Agency; London Regional Cancer Program, Canada; Beatson Institute for Cancer Research, Scotland; The Alfred; Beacon Hospital, Ireland
Recruiting
-
Posted: February 12th, 2019, 3:00pm GMT
Condition: Pancreatic Neoplasms
Interventions: Drug: Propranolol and etodolac; Other: Placebo
Sponsors: Assaf-Harofeh Medical Center; Sheba Medical Center
Recruiting
-
Posted: January 14th, 2019, 3:00pm GMT
Condition: Colorectal Cancer
Interventions: Other: Erector spinae plane block; Other: Quadratus lumborum block; Drug: Propofol; Drug: Fentanyl NCS; Drug: Atracurium Injectable Product; Other: Endotracheal intubation; Drug: Anesthesia Maintenance; Drug: Muscle Relaxation
Sponsor: Mansoura University
Not yet recruiting
-
Posted: January 10th, 2019, 3:00pm GMT
Condition: Advanced Solid Tumors
Interventions: Drug: ASP1951; Drug: pembrolizumab
Sponsor: Astellas Pharma Global Development, Inc.
Recruiting
-
Posted: December 18th, 2018, 3:00pm GMT
Condition: Prostate Cancer
Interventions: Drug: Prednisone; Drug: Apalutamide; Drug: Abiraterone Acetate; Drug: LHRH Agonist or Antagonist
Sponsors: Dana-Farber Cancer Institute; Janssen Scientific Affairs, LLC
Recruiting
-
Posted: December 3rd, 2018, 3:00pm GMT
Condition: Breast Neoplasm
Intervention:
Sponsors: St. Olavs Hospital; Norwegian University of Science and Technology
Recruiting
-
Posted: November 20th, 2018, 3:00pm GMT
Condition: Renal Tumor
Intervention: Radiation: Stereotactic Ablative Radiotherapy
Sponsor: University Health Network, Toronto
Recruiting
-
Posted: November 7th, 2018, 3:00pm GMT
Condition: Breast Cancer
Interventions: Diagnostic Test: digital breast tomosynthesis; Diagnostic Test: standard two dimension digital mammogram
Sponsor: King's College Hospital NHS Trust
Recruiting
-
Posted: October 19th, 2018, 2:00pm GMT
Conditions: Breast Cancer; Acute Pain; Anesthesia
Interventions: Procedure: PVB group; Procedure: MTP block group; Procedure: Control Group
Sponsor: Ottawa Hospital Research Institute
Not yet recruiting
-
Posted: October 11th, 2018, 2:00pm GMT
Condition: Breast Cancer
Intervention: Device: MRI scan
Sponsor: Maastricht University Medical Center
Recruiting
-
Posted: September 18th, 2018, 2:00pm GMT
Condition: Prostate Cancer
Intervention: Behavioral: High Intensity Interval Training bout
Sponsor: Rigshospitalet, Denmark
Recruiting
-
Posted: August 2nd, 2018, 2:00pm GMT
Condition: Adrenocortical Carcinoma
Intervention: Drug: Cabozantinib-s-malate
Sponsor: Wuerzburg University Hospital
Recruiting
-
Posted: July 11th, 2018, 2:00pm GMT
Conditions: ENSAT Stage I Adrenal Cortex Carcinoma; ENSAT Stage II Adrenal Cortex Carcinoma; ENSAT Stage III Adrenal Cortex Carcinoma
Interventions: Drug: Cisplatin; Drug: Etoposide; Drug: Mitotane; Procedure: Quality-of-Life Assessment
Sponsors: M.D. Anderson Cancer Center; Amercian Australian Asian Adrenal Alliance (A5); European Network for the Study of Adrenal Tumors (ENS@T)
Recruiting
-
Posted: May 22nd, 2018, 2:00pm GMT
Condition: Metastatic Hormone-Sensitive Prostate Cancer
Interventions: Biological: PROSTVAC-V; Biological: PROSTVAC-F; Drug: Nivolumab; Drug: Ipilimumab; Biological: Neoantigen DNA vaccine; Device: TriGrid Delivery System; Procedure: Tumor biopsy; Procedure: Peripheral blood; Procedure: Fecal samples; Procedure: Leukapheresis
Sponsors: Washington University School of Medicine; Bristol-Myers Squibb; Prostate Cancer Foundation; BJH Foundation
Recruiting
-
Posted: February 9th, 2018, 3:00pm GMT
Conditions: Barrett Esophagus; Barrett Adenocarcinoma; Esophagus Neoplasm
Interventions: Procedure: Endoscopic mucosal resection; Procedure: Endoscopic submucosal dissection
Sponsor: Universitätsklinikum Hamburg-Eppendorf
Recruiting
-
Posted: January 25th, 2018, 3:00pm GMT
Condition: Endocrine Tumor
Intervention:
Sponsor: Central Hospital, Nancy, France
Recruiting
-
Posted: December 19th, 2017, 3:00pm GMT
Condition: Breast Cancer Screening
Interventions: Diagnostic Test: DBT+s2D; Diagnostic Test: 2D-FFDM
Sponsors: University Hospital Muenster; German Research Foundation
Recruiting
-
Posted: December 15th, 2017, 3:00pm GMT
Conditions: Adrenal Gland Neoplasm; Hypertension; Bone Diseases, Metabolic; Cardiovascular Disease; Hyperinsulinemia
Intervention:
Sponsors: National Human Genome Research Institute (NHGRI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting
-
Posted: December 12th, 2017, 3:00pm GMT
Conditions: Metastatic Carcinoma in the Adrenal Cortex; Stage III Adrenal Cortex Carcinoma AJCC v8; Stage IV Adrenal Cortex Carcinoma AJCC v8; Unresectable Adrenal Cortex Carcinoma
Interventions: Drug: Cabozantinib; Other: Pharmacogenomic Study; Other: Pharmacokinetic Study
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: December 5th, 2017, 3:00pm GMT
Condition: Prostatic Neoplasm
Interventions: Drug: Estetrol; Drug: Placebo Oral Tablet
Sponsor: Pantarhei Oncology B.V.
Recruiting
-
Posted: September 13th, 2017, 2:00pm GMT
Condition: Major Depressive Disorder
Interventions: Drug: Fecal microbiota capsules; Drug: Placebo oral capsule
Sponsor: Psychiatric Hospital of the University of Basel
Recruiting
-
Posted: July 13th, 2017, 2:00pm GMT
Conditions: Acute Upper Gastrointestinal Bleeding; Tumor Bleeding
Interventions: Device: Over-the-scope Clips; Device: Hemo-clipping; Device: thermo-coagulation; Drug: Epinephrine
Sponsors: Chinese University of Hong Kong; Queen Mary Hospital, Hong Kong; The First Affiliated Hospital of Soochow University; Beijing Friendship Hospital; Zhejiang University; Ningbo No. 1 Hospital
Recruiting
-
Posted: July 2nd, 2017, 2:00pm GMT
Conditions: Pheochromocytoma; Paraganglioma; Neuroendocrine Tumors; Neuroendocrine Neoplasms
Interventions: Drug: Lu-177-DOTATATE; Drug: Ga-68-DOTATATE; Drug: F-18-FDG; Drug: Amino Acid solution
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: June 5th, 2017, 2:00pm GMT
Conditions: Pheochromocytoma; Paraganglioma
Interventions: Drug: Phenoxybenzamine; Drug: Doxazosin
Sponsor: University of California, Los Angeles
Recruiting
-
Posted: May 24th, 2017, 2:00pm GMT
Conditions: Paraganglioma; Gastrointestinal Stromal Tumors; Carcinoma, Renal Cell; Renal Neoplasms; Pheochromocytoma
Intervention: Drug: SGI-110 (guadecitabine)
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: May 15th, 2017, 2:00pm GMT
Condition: Prostate Carcinoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Propranolol Hydrochloride; Other: Questionnaire Administration; Other: Survey Administration
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting
-
Posted: April 25th, 2017, 2:00pm GMT
Conditions: Adrenocortical Carcinoma; Peritoneal Carcinomatosis
Interventions: Drug: Cisplatin; Drug: Sodium thiosulfate; Procedure: Cytoreductive surgery
Sponsor: Columbia University
Recruiting
-
Posted: April 21st, 2017, 2:00pm GMT
Conditions: Hormone-Resistant Prostate Cancer; Recurrent Prostate Carcinoma; Stage I Prostate Cancer; Stage II Prostate Cancer; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer
Interventions: Procedure: Biospecimen Collection; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Recruiting
-
Posted: February 16th, 2017, 3:00pm GMT
Conditions: Metastatic Malignant Neoplasm in Lymph Node; Metastatic Malignant Neoplasm in the Adrenal Gland; Metastatic Malignant Neoplasm in the Lung; Metastatic Malignant Neoplasm in the Pancreas; Metastatic Malignant Neoplasm in the Skin; Metastatic Malignant Neoplasm in the Soft Tissues; Metastatic Renal Cell Carcinoma; Sarcomatoid Renal Cell Carcinoma; Stage II Renal Cell Cancer AJCC v7; Stage III Renal Cell Cancer AJCC v7; Unclassified Renal Cell Carcinoma
Interventions: Procedure: Conventional Surgery; Biological: Nivolumab; Other: Patient Observation; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
Sponsors: National Cancer Institute (NCI); Canadian Cancer Trials Group
Recruiting
-
Posted: February 13th, 2017, 3:00pm GMT
Conditions: Healthy Subject; Stage 0 Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage IIA Breast Cancer; Stage IIB Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer
Interventions: Procedure: Biospecimen Collection; Procedure: Functional Magnetic Resonance Imaging; Other: Questionnaire Administration
Sponsors: Stanford University; National Cancer Institute (NCI)
Recruiting
-
Posted: February 13th, 2017, 3:00pm GMT
Condition: Endocrine Disease
Interventions: Other: Data Collection; Behavioral: Follow Up
Sponsor: M.D. Anderson Cancer Center
Recruiting
-
Posted: February 10th, 2017, 3:00pm GMT
Conditions: Acute Leukemia; Adenomatous Polyposis; Adrenocortical Carcinoma; AML; BAP1 Tumor Predisposition Syndrome; Carney Complex; Choroid Plexus Carcinoma; Constitutional Mismatch Repair Deficiency Syndrome; Diamond-Blackfan Anemia; DICER1 Syndrome; Dyskeratosis Congenita; Emberger Syndrome; Familial Acute Myeloid Leukemia; Familial Adenomatous Polyposis; Fanconi Anemia; Familial Cancer; Familial Wilms Tumor; Familial Neuroblastoma; GIST; Hereditary Breast and Ovarian Cancer; Hereditary Paraganglioma-Pheochromocytoma Syndrome; Hodgkin Lymphoma; Juvenile Polyposis; Li-Fraumeni Syndrome; Lynch Syndrome; MDS; Melanoma Syndrome; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Neuroblastoma; Neurofibromatosis Type 1; Neurofibromatosis Type II; Nevoid Basal Cell Carcinoma Syndrome; Non Hodgkin Lymphoma; Noonan Syndrome and Other Rasopathy; Overgrowth Syndromes; Pancreatic Cancer; Peutz-Jeghers Syndrome; Pheochromocytoma/Paraganglioma; PTEN Hamartoma Tumor Syndrome; Retinoblastoma; Rhabdoid Tumor Predisposition Syndrome; Rhabdomyosarcoma; Rothmund-Thomson Syndrome; Tuberous Sclerosis; Von Hippel-Lindau Disease
Intervention:
Sponsor: St. Jude Children's Research Hospital
Recruiting
-
Posted: January 9th, 2017, 3:00pm GMT
Condition: Previously Untreated Acute Myeloid Leukemia
Interventions: Biological: Samalizumab (BAML-16-001-S1); Biological: BI 836858 (BAML-16-001-S2); Other: Laboratory Biomarker Analysis; Drug: Daunorubicin (BAML-16-001-S1); Drug: Cytarabine (BAML-16-001-S1); Drug: Azacitidine (BAML-16-001-S2); Drug: AG-221 (BAML-16-001-S3); Drug: Azacitidine (BAML-16-001-S3); Drug: Entospletinib (BAML-16-001-S4); Drug: Azacitidine (BAML-16-001-S4); Drug: Entospletinib (BAML-16-001-S5); Drug: Decitabine (BAML-16-001-S5); Drug: Entospletinib (BAML-16-001-S6); Drug: Azacitidine (BAML-16-001-S6); Drug: Daunorubicin (BAML-16-001-S6); Drug: Cytarabine (BAML-16-001-S6); Drug: Pevonedistat (BAML-16-001-S9); Drug: Azacitidine (BAML-16-001-S9); Drug: AG-120 (BAML-16-001-S16); Drug: Azacitidine (BAML-16-001-S16); Drug: Gilteritinib (BAML-16-001-S8); Drug: Decitabine (BAML-16-001-S8)
Sponsor: Beat AML, LLC
Recruiting
-
Posted: January 2nd, 2017, 3:00pm GMT
Conditions: Malignant Adrenal Gland Pheochromocytoma; Malignant Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma
Interventions: Other: Laboratory Biomarker Analysis; Drug: Lenvatinib; Other: Quality-of-Life Assessment
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting
-
Posted: December 6th, 2016, 3:00pm GMT
Conditions: Solitary Pulmonary Nodule; Multiple Pulmonary Nodules
Intervention: Procedure: transbronchial biopsy
Sponsors: University of Pennsylvania; Andrew Haas; Anil Vachani; Anthony Lanfranco; Kevin Ma; Jeffrey Thompson; Edmund Moon
Recruiting
-
Posted: November 3rd, 2016, 2:00pm GMT
Condition: Prostate Cancer
Interventions: Behavioral: High Intensity Interval Training; Behavioral: Usual Care Observational Control
Sponsor: Rigshospitalet, Denmark
Recruiting
-
Posted: June 15th, 2016, 2:00pm GMT
Condition: Cancer
Interventions: Behavioral: Mindfulness Based Cancer Recovery (MBCR); Behavioral: Tai Chi/Qigong (TCQ) for Cancer Patients
Sponsors: Linda E. Carlson; University of Calgary; Alberta Health Services; Tom Baker Cancer Centre; Princess Margaret Hospital, Canada
Recruiting
-
Posted: April 15th, 2016, 2:00pm GMT
Condition: Malignant Neoplasms of Male Genital Organs
Interventions: Procedure: Caudal Nerve Block (CNB); Drug: Ropivacaine; Drug: Epinephrine; Drug: Decadron; Drug: Clonidine; Drug: Propofol; Behavioral: Phone Call
Sponsors: M.D. Anderson Cancer Center; Merck Sharp & Dohme Corp.
Recruiting
-
Posted: March 29th, 2016, 2:00pm GMT
Conditions: Carcinoma of Unknown Primary Origin; Kidney Medullary Carcinoma; Malignant Germ Cell Tumor; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Malignant Solid Neoplasm; Metastatic Paraganglioma; Metastatic Penile Carcinoma; Paraganglioma; Skin Squamous Cell Carcinoma; Small Cell Carcinoma; Stage IV Adrenal Cortex Carcinoma AJCC v7; Stage IV Penile Cancer AJCC v7; Stage IV Renal Cell Cancer AJCC v7; Unresectable Solid Neoplasm; Vascular Neoplasm
Interventions: Other: Laboratory Biomarker Analysis; Biological: Pembrolizumab; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: February 3rd, 2016, 3:00pm GMT
Condition: Adrenocortical Carcinoma
Intervention: Drug: Pembrolizumab
Sponsors: Memorial Sloan Kettering Cancer Center; Merck Sharp & Dohme Corp.
Recruiting
-
Posted: December 22nd, 2015, 3:00pm GMT
Conditions: Advanced Solid Tumors (Part A/B/C/D); Non-small Cell Lung Cancer (Part E); Melanoma (Part E); Squamous Cell Cancer of the Head and Neck (Part E); Triple Negative Breast Cancer (Part F); Adrenocortical Carcinoma (Part G); Mesothelioma (Part G); High-circulating Myeloid-derived Suppressor Cells (Part H)
Interventions: Drug: IPI-549; Drug: Nivolumab
Sponsor: Infinity Pharmaceuticals, Inc.
Recruiting
-
Posted: June 2nd, 2015, 2:00pm GMT
Condition: Neoplasms
Intervention: Behavioral: Exercise for Cancer Patients
Sponsor: University of Rochester
Recruiting
-
Posted: May 25th, 2015, 2:00pm GMT
Condition: Anesthesia
Interventions: Procedure: Serratus Block; Procedure: Placebo Block; Drug: ropivacaine; Drug: epinephrine; Other: sterile saline
Sponsor: Women's College Hospital
Recruiting
-
Posted: February 20th, 2015, 3:00pm GMT
Conditions: Obesity; Inflammation
Intervention:
Sponsor: USDA, Western Human Nutrition Research Center
Recruiting
-
Posted: December 24th, 2014, 3:00pm GMT
Conditions: Adrenal Incidentaloma; Adrenocortical Carcinoma
Intervention:
Sponsors: University Medical Center Groningen; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); VU University Medical Center; Radboud University; Leiden University Medical Center; Maastricht University Medical Center; UMC Utrecht; Erasmus Medical Center; Martini Hospital Groningen; Canisius-Wilhelmina Hospital; Diakonessenhuis, Utrecht; Isala; Haga Hospital; St. Antonius Hospital; Kennemer Gasthuis; Maxima Medical Center; Medical Center Alkmaar; Medical Centre Leeuwarden; Meander Medical Center; Medisch Spectrum Twente; Onze Lieve Vrouwe Gasthuis; Rijnstate Hospital; Elisabeth-TweeSteden Ziekenhuis; Tergooi Hospital; Vlietland Ziekenhuis; Scheper Hospital; Flevo Hospital
Recruiting
-
Posted: November 27th, 2014, 3:00pm GMT
Conditions: Locally Advanced Paraganglioma; Metastatic Adrenal Gland Pheochromocytoma; Metastatic Paraganglioma; Regional Adrenal Gland Pheochromocytoma; Unresectable Adrenal Gland Pheochromocytoma; Unresectable Paraganglioma
Interventions: Drug: Cabozantinib S-malate; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: November 7th, 2014, 3:00pm GMT
Conditions: Low-Grade Gliomas; Malignant Neoplasms, Brain; Soft Tissue Neoplasms
Intervention: Drug: MEK162
Sponsors: Children's Hospital Los Angeles; Dana-Farber Cancer Institute
Recruiting
-
Posted: April 14th, 2014, 2:00pm GMT
Conditions: Neuroblastoma; Ganglioneuroblastoma
Intervention: Radiation: Proton Beam Radiation Therapy
Sponsors: Massachusetts General Hospital; National Cancer Institute (NCI)
Recruiting
-
Posted: September 24th, 2013, 2:00pm GMT
Conditions: Pheochromocytoma; Adrenal Incidentaloma
Intervention: Procedure: Removal of adrenal tumor
Sponsor: University of Aarhus
Recruiting
-
Posted: April 17th, 2013, 2:00pm GMT
Condition: Bone Metastasis
Intervention: Device: ExAblate MRgFUS
Sponsor: InSightec
Recruiting
-
Posted: November 16th, 2012, 3:00pm GMT
Condition: LOW AND INTERMEDIATE PAEDIATRIC NEUROBLASTOMA AND NEONATAL SUPRARENAL MASSES
Intervention: Drug: chemotherapy
Sponsor: Instituto de Investigacion Sanitaria La Fe
Recruiting
-
Posted: June 27th, 2011, 2:00pm GMT
Condition: Cushing Syndrome
Intervention: Procedure: surgery
Sponsors: Samsung Medical Center; Asan Medical Center; Severance Hospital; Konkuk University Medical Center
Recruiting
-
Posted: June 8th, 2011, 2:00pm GMT
Condition: Prostate Cancer
Interventions: Radiation: radiation therapy; Radiation: Whole-pelvic radiotherapy (WPRT)
Sponsors: Radiation Therapy Oncology Group; National Cancer Institute (NCI); NRG Oncology
Recruiting
-
Posted: November 23rd, 2010, 3:00pm GMT
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
Sponsor: Region Skane
Recruiting
-
Posted: November 2nd, 2009, 3:00pm GMT
Conditions: Endocrine Tumors; Thyroid Neoplasms; Parathyroid Neoplasms; Adrenal Neoplasm; Neuroblastoma
Intervention:
Sponsor: National Cancer Institute (NCI)
Recruiting
-
Posted: June 18th, 2008, 2:00pm GMT
Condition: Adrenocortical Tumor
Intervention:
Sponsor: St. Jude Children's Research Hospital
Recruiting
-
Posted: January 8th, 2008, 3:00pm GMT
Condition: Neuroblastoma
Intervention: Other: Tumor and Marrow Markers
Sponsors: Memorial Sloan Kettering Cancer Center; Southern Illinois University; Spanish National Cancer Center; St. Jude Children's Research Hospital; Washington University School of Medicine; University of Texas; Weill Medical College of Cornell University
Recruiting
-
Posted: June 29th, 2000, 2:00pm GMT
Condition: Adrenal Gland Neoplasm
Intervention:
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting